Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + ESHAP in Relapsed/Refractory Non-Hodgkin's Lymphoma
NCT02431403Phase 2Unknown
- Sponsor
- Pusan National University Hospital
- Start
- Feb 2015
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in non-Hodgkin lymphoma (NHL), sponsored by Pusan National University Hospital. Status: unknown.
02
Drugs
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT02431403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431403.